Cartoonist Scott Adams, who said earlier this year his prostate cancer has metastasized, has publicly asked President Trump to intervene after his health plan approved a new FDA drug but stalled on scheduling the IV infusion; conservative voices and senior aides signaled they are tracking the situation while Adams describes rapid decline and daily pain, and the story spotlights the tension between patient urgency and large health system bureaucracy.
Adams, best known for creating the “Dilbert” comic strip, announced his metastatic prostate cancer diagnosis months ago and has been candid about how quickly his condition is worsening. He says his care team approved the new therapy Pluvicto, a drug that many patients have found helpful when timed right, but scheduling problems are blocking treatment. He wrote in a that his healthcare provider, Kaiser Permanente – Northern California, approved his application to receive a new FDA-approved drug Pluvicto.
“But they have dropped the ball in scheduling the brief IV to administer it and I can’t seem to fix that. I am declining fast,” Adams wrote, a blunt appeal that makes clear how fragile timing can be for cancer care. There is a raw, impatient tone to his plea that fits a patient who believes prompt access could meaningfully extend his life. That desperation is why he reached out beyond his medical team and toward political leaders.
“I will ask President Trump if he can get Kaiser of Northern California to respond and schedule it for Monday. That will give me a fighting chance to stick around on this planet a little bit longer. It is not a cure, but it does give good results to many people.”
https://x.com/ScottAdamsSays/status/1984915690634252352
When high-profile patients go public, elected officials often step in or at least offer to help cut through red tape, and in this case that pattern held. Health and Human Services Secretary Robert F. Kennedy Jr. responded to Adams’ viral post, asking how to reach him, and made the simple, human offer: “The President wants to help.”
White House personnel also signaled attention to the situation. Dan Scavino, White House deputy chief of staff and head of personnel, also saying, “No need till [sic] wait until Monday—@realDonaldTrump, @RobertKennedyJr, and @DrOz are all tracking now, Scott.” That public tracking sends a quick message: the administration sees a case where rapid action could matter and is willing to apply pressure on a large health system.
There is a clear political angle here that conservative readers will recognize: when big systems move slowly, a responsive executive can force a faster outcome. That does not solve systemic problems, but it does show how public appeals can get attention when private channels stall. Adams’ story reads like a test of whether institutions bend under citizen pressure or remain mired in process.
Adams has been frank about his daily reality, posting videos and updates that put a face to the clinical facts. He said in a video posted to his YouTube channel in May that he is in pain every day and has been using a walker for months. “If you’re wondering if I’ll get better, the answer is no, it will only get worse,” he said on his “Real Coffee with Scott Adams” show. “There’s only one direction this goes.”
Those lines are stark. They remind readers that behind every procedural delay is a person whose time is finite and whose choices matter now. Medical approvals and scheduling are one thing, but when a patient is public and vulnerable, there’s public pressure to make systems act faster and more humanely.
Prostate cancer statistics underline why this matters to many families. Roughly 1 in 8 men will be diagnosed with prostate cancer during their lifetime, and prostate cancer stands as the second leading cause of cancer death among American men after lung cancer. That prevalence helps explain the attention and why any new treatment that offers meaningful outcomes attracts urgent interest.
